Status:
COMPLETED
Young Adults' Reactions to Low Nicotine Cigarette Advertising
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking
Eligibility:
All Genders
21-29 years
Phase:
NA
Brief Summary
Reducing the nicotine content in combustible cigarettes to non-addictive levels has demonstrated promise as a safe and effective public health strategy for decreasing tobacco-caused morbidity and mort...
Eligibility Criteria
Inclusion
- Aged 21-29
- Able to use a computer or related technology (such as a smartphone or tablet) with reliable internet access and willing to use the device to participate in the research study.
- Have a valid email address and willing to use email to participate in the research study. Participants without an existing email account who are willing to create one for study purposes are eligible to participate.
- Additional inclusion criteria vary by smoking status.
Exclusion
- Currently enrolled in a cessation program
- Report consuming ≥ 25 alcohol-containing drinks per week
- Report a history or current psychiatric diagnosis or severe medical condition
- Are color-blind or have another visual impairment (e.g., partial blindness, uncorrected cataract)
- Self-report being pregnant and/or lactating
- Are diagnosed with or test positive for COVID-19. Participants who report having traveled to a high-risk area in the past 2 weeks or who have been in close contact with someone confirmed or being evaluated for COVID-19 will be placed on a waitlist. Waitlisted participants will be asked to self-isolate for 14 days after exposure (even without symptoms) and will be re-screened for eligibility post self-isolation.
- Additional, general reasons for exclusion include:
- Significant non-compliance with protocol and/or study design as determined by the Principal Investigator (PI) at any point throughout the study.
- Past, current, anticipated, or pending enrollment in another research program over the study period that could potentially impact study data as determined by the PI.
- Any medical condition, illness, disorder, adverse event (AE), or concomitant medication that could compromise participant safety or significantly impact study performance as determined by the PI. Subjects may be deemed ineligible for any of the aforementioned reasons at any point throughout the study, as well as during the initial telephone screen.
Key Trial Info
Start Date :
May 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04906148
Start Date
May 27 2021
End Date
August 11 2023
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104